Molecular and clinical risk markers in colon cancer trials.

Abstract excerpt

Although there is a great deal of information concerning the risk factors for colorectal cancer, progress has been slow in determining methods of chemoprevention. In part this is because colorectal cancer consists of a series of events over 10-15 years or more, which affects only 3-5% of the population. Risk markers for use in patient selection are needed to decrease the sample size needed. In addition, there is...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adenoma
• Share to Adenomatous Polyposis Coli
• Share to Biomarkers, Tumor